Cargando…

Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes

AIMS/HYPOTHESIS: Hypoxia in the initial days after islet transplantation leads to considerable loss of islet mass and contributes to disappointing outcomes in the clinical setting. The aim of the present study was to investigate whether co-transplantation of human non-endothelial bone marrow-derived...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, João Paulo M. C. M., Leuckx, Gunter, Sterkendries, Peter, Korf, Hannelie, Bomfim-Ferreira, Gabriela, Overbergh, Lutgart, Vaes, Bart, Heimberg, Harry, Gysemans, Conny, Mathieu, Chantal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518081/
https://www.ncbi.nlm.nih.gov/pubmed/27704164
http://dx.doi.org/10.1007/s00125-016-4120-3
_version_ 1783418389394358272
author Cunha, João Paulo M. C. M.
Leuckx, Gunter
Sterkendries, Peter
Korf, Hannelie
Bomfim-Ferreira, Gabriela
Overbergh, Lutgart
Vaes, Bart
Heimberg, Harry
Gysemans, Conny
Mathieu, Chantal
author_facet Cunha, João Paulo M. C. M.
Leuckx, Gunter
Sterkendries, Peter
Korf, Hannelie
Bomfim-Ferreira, Gabriela
Overbergh, Lutgart
Vaes, Bart
Heimberg, Harry
Gysemans, Conny
Mathieu, Chantal
author_sort Cunha, João Paulo M. C. M.
collection PubMed
description AIMS/HYPOTHESIS: Hypoxia in the initial days after islet transplantation leads to considerable loss of islet mass and contributes to disappointing outcomes in the clinical setting. The aim of the present study was to investigate whether co-transplantation of human non-endothelial bone marrow-derived multipotent adult progenitor cells (MAPCs), which are non-immunogenic and can secrete angiogenic growth factors during the initial days after implantation, could improve islet engraftment and survival. METHODS: Islets (150) were co-transplanted, with or without human MAPCs (2.5 × 10(5)) as separate or composite pellets, under the kidney capsule of syngeneic alloxan-induced diabetic C57BL/6 mice. Blood glucose levels were frequently monitored and IPGTTs were carried out. Grafts and serum were harvested at 2 and 5 weeks after transplantation to assess outcome. RESULTS: Human MAPCs produced high amounts of angiogenic growth factors, including vascular endothelial growth factor, in vitro and in vivo, as demonstrated by the induction of neo-angiogenesis in the chorioallantoic membrane assay. Islet–human MAPC co-transplantation as a composite pellet significantly improved the outcome of islet transplantation as measured by the initial glycaemic control, diabetes reversal rate, glucose tolerance and serum C-peptide concentration compared with the outcome following transplantation of islets alone. Histologically, a higher blood vessel area and density in addition to a higher vessel/islet ratio were detected in recipients of islet–human MAPC composites. CONCLUSIONS/INTERPRETATION: The present data suggest that co-transplantation of mouse pancreatic islets with human MAPCs, which secrete high amounts of angiogenic growth factors, enhance islet graft revascularisation and subsequently improve islet graft function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-016-4120-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
format Online
Article
Text
id pubmed-6518081
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-65180812019-06-05 Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes Cunha, João Paulo M. C. M. Leuckx, Gunter Sterkendries, Peter Korf, Hannelie Bomfim-Ferreira, Gabriela Overbergh, Lutgart Vaes, Bart Heimberg, Harry Gysemans, Conny Mathieu, Chantal Diabetologia Article AIMS/HYPOTHESIS: Hypoxia in the initial days after islet transplantation leads to considerable loss of islet mass and contributes to disappointing outcomes in the clinical setting. The aim of the present study was to investigate whether co-transplantation of human non-endothelial bone marrow-derived multipotent adult progenitor cells (MAPCs), which are non-immunogenic and can secrete angiogenic growth factors during the initial days after implantation, could improve islet engraftment and survival. METHODS: Islets (150) were co-transplanted, with or without human MAPCs (2.5 × 10(5)) as separate or composite pellets, under the kidney capsule of syngeneic alloxan-induced diabetic C57BL/6 mice. Blood glucose levels were frequently monitored and IPGTTs were carried out. Grafts and serum were harvested at 2 and 5 weeks after transplantation to assess outcome. RESULTS: Human MAPCs produced high amounts of angiogenic growth factors, including vascular endothelial growth factor, in vitro and in vivo, as demonstrated by the induction of neo-angiogenesis in the chorioallantoic membrane assay. Islet–human MAPC co-transplantation as a composite pellet significantly improved the outcome of islet transplantation as measured by the initial glycaemic control, diabetes reversal rate, glucose tolerance and serum C-peptide concentration compared with the outcome following transplantation of islets alone. Histologically, a higher blood vessel area and density in addition to a higher vessel/islet ratio were detected in recipients of islet–human MAPC composites. CONCLUSIONS/INTERPRETATION: The present data suggest that co-transplantation of mouse pancreatic islets with human MAPCs, which secrete high amounts of angiogenic growth factors, enhance islet graft revascularisation and subsequently improve islet graft function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-016-4120-3) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2016-10-04 2017 /pmc/articles/PMC6518081/ /pubmed/27704164 http://dx.doi.org/10.1007/s00125-016-4120-3 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Cunha, João Paulo M. C. M.
Leuckx, Gunter
Sterkendries, Peter
Korf, Hannelie
Bomfim-Ferreira, Gabriela
Overbergh, Lutgart
Vaes, Bart
Heimberg, Harry
Gysemans, Conny
Mathieu, Chantal
Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes
title Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes
title_full Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes
title_fullStr Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes
title_full_unstemmed Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes
title_short Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes
title_sort human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518081/
https://www.ncbi.nlm.nih.gov/pubmed/27704164
http://dx.doi.org/10.1007/s00125-016-4120-3
work_keys_str_mv AT cunhajoaopaulomcm humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT leuckxgunter humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT sterkendriespeter humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT korfhannelie humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT bomfimferreiragabriela humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT overberghlutgart humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT vaesbart humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT heimbergharry humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT gysemansconny humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes
AT mathieuchantal humanmultipotentadultprogenitorcellsenhanceisletfunctionandrevascularisationwhencotransplantedasacompositepelletinamousemodelofdiabetes